Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD

References

• FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
   PubMed Web of Science ®Google Scholar
• RennardSIVestboJNatural histories of chronic obstructive pulmonary diseaseProc Am Thorac Soc20085987888319056710
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD-2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/912016
   Google Scholar
• DonaldsonGSeemungalTBhowmikAWedzichaJRelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• MiravitllesMFerrerMPontAEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax200459538739515115864
   PubMed Web of Science ®Google Scholar
• MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJRodriguez-RoisinRFrequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?COPD20107427628420673037
   PubMedGoogle Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• HoogendoornMHoogenveenRTRutten-van MölkenMPVestboJFeenstraTLCase fatality of COPD exacerbations: a meta-analysis and statistical modelling approachEur Respir J201137350851520595157
   PubMed Web of Science ®Google Scholar
• NiewoehnerDELokhnyginaYRiceKRisk indexes for exacerbations and hospitalizations due to COPDChest20071311202817218552
   PubMed Web of Science ®Google Scholar
• BakerCLZouKHSuJRisk assessment of readmissions following an initial COPD-related hospitalizationInt J Chron Obstruct Pulmon Dis2013855155924348031
   PubMed Web of Science ®Google Scholar
• ElixhauserAAuDHPodulkaJReadmissions for Chronic Obstructive Pulmonary Disease, 2008: Statistical Brief #121 [Internet]Healthcare Cost and Utilization Project (HCUP) Statistical BriefsRockville (MD) Available from: http://www.ncbi.nlm.nih.gov/books/NBK65392/Accessed September 1, 2016
   Google Scholar
• FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
   PubMed Web of Science ®Google Scholar
• CMSMedicare Hospital Quality Chartbook – Performance Report on Outcome Measures, September 2013 – Medicare-Hospital-Quality-Chartbook-2013.pdf Available from: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Downloads/-Medicare-Hospital-Quality-Chartbook-2013.pdfAccessed September 1, 2016
   Google Scholar
• HinesALBarrettMLJiangHJSteinerCAConditions with the largest number of adult hospital readmissions by payer 20112014 [cited January 6, 2016]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK206781/912016
   Google Scholar
• JencksSFWilliamsMVColemanEARehospitalizations among patients in the Medicare fee-for-service programN Engl J Med2009360141418142819339721
   PubMed Web of Science ®Google Scholar
• SharmaGKuoY-FFreemanJLZhangDDGoodwinJSOutpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary diseaseArch Intern Med2010170181664167020937926
   PubMed Web of Science ®Google Scholar
• HansenLOGreenwaldJLBudnitzTProject BOOST: effectiveness of a multihospital effort to reduce rehospitalizationJ Hosp Med20138842142723873709
   PubMed Web of Science ®Google Scholar
• MarkleyJAndowVSabharwalKWangZFennellEDusekRA project to reengineer discharges reduces 30-day readmission ratesAm J Nurs201311375564
   PubMed Web of Science ®Google Scholar
• KrishnanJAGussinHAPrieto-CenturionVSullivanJLZaidiFThomashowBMIntegrating COPD into patient-centered hospital readmissions reduction programsChronic Obstr Pulm Dis201521708025927076
   PubMedGoogle Scholar
• Prieto-CenturionVMarkosMARameyNIInterventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic reviewAnn Am Thorac Soc201411341742424423379
   PubMedGoogle Scholar
• JenningsJHThavarajahKMendezMPEichenhornMKvalePYessayanLPredischarge bundle for patients with acute exacerbations of COPD to reduce readmissions and ED visits: a randomized controlled trialChest201514751227123425940250
   PubMed Web of Science ®Google Scholar
• TashkinDPFabbriLMLong-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespir Res20101114921034447
   PubMed Web of Science ®Google Scholar
• KewKMMavergamesCWaltersJAELong-acting beta2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201310CD010177
   PubMed Web of Science ®Google Scholar
• CheyneLIrvin-SellersMJWhiteJTiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20159CD009552
   Google Scholar
• CalverleyPMARabeKFGoehringU-MRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
   PubMed Web of Science ®Google Scholar
• FuAZSunSXHuangXAminANLower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20151090991525999706
   PubMed Web of Science ®Google Scholar
• SharifRParekhTMPiersonKSKuoY-FSharmaGPredictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary diseaseAnn Am Thorac Soc201411568569424784958
   PubMedGoogle Scholar
• SinghGZhangWKuoY-FSharmaGAssociation of psychological disorders with 30-day readmission rates in patients with COPDChest2016149490591526204260
   PubMed Web of Science ®Google Scholar
• AmalakuhanBKiljanekLParvathaneniAHesterMCheriyathPFischmanDA prediction model for COPD readmissions: catching up, catching our breath, and improving a national problemJ Community Hosp Intern Med Perspect20122110.3402/jchimp.v2i1.9915
   PubMedGoogle Scholar
• CrinerGJBourbeauJDiekemperRLExecutive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest2015147488389325320966
   PubMed Web of Science ®Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
   PubMed Web of Science ®Google Scholar
• LindenauerPKShiehM-SPekowPSStefanMSUse and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary diseaseAnn Am Thorac Soc20141181186119425167078
   PubMedGoogle Scholar
• BakerCLZouKHSuJLong-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims dataInt J Chron Obstruct Pulmon Dis2014943143924833898
   PubMed Web of Science ®Google Scholar
• TurnerAEjioforSTurnerAPharmacotherapies for COPDClin Med Insights Circ Respir Pulm Med20137173423700381
   PubMedGoogle Scholar
• CockcroftDWSwystunVAFunctional antagonism: tolerance produced by inhaled beta 2 agonistsThorax19965110105110568984693
   PubMed Web of Science ®Google Scholar
• van der WoudeHJWinterTHAalbersRDecreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonistsThorax200156752953511413351
   PubMed Web of Science ®Google Scholar